Select a Size
| Size/SKU | Availability | Price |
|---|
About This Item
biological source
rabbit skeletal muscle
Quality Segment
form
lyophilized
specific activity
≥300 U/mg, 25 °C, 750 U/mg, 37 °C
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated (hygroscopic)
solubility
0.1 M imidazole buffer, pH 6.6: soluble, 0.5% NaHCO3, pH 9.0: soluble
foreign activity
ATPase, hexokinase, myokinase <0.001%
shipped in
ambient
storage temp.
−20°C
General description
Preparation Note
Other Notes
Legal Information
Disclaimer
1 of 1
This Item | |||
|---|---|---|---|
| description - | description Type I, salt-free, lyophilized powder, ≥150 units/mg protein | description Creatine Phosphokinase, Porcine Heart, CAS 9001-15-4, is a native creatine phosphokinase that catalyzes the reversible conversion of creatine and ATP to creatine phosphate and ADP. | description Type II, ammonium sulfate suspension, 350-600 units/mg protein |
| biological source rabbit skeletal muscle | biological source - | biological source - | biological source rabbit muscle |
| specific activity ≥300 U/mg, 25 °C, 750 U/mg, 37 °C | specific activity ≥150 units/mg protein | specific activity ≥300 U/mg | specific activity 350-600 units/mg protein |
| form lyophilized | form salt-free, lyophilized powder | form lyophilized | form ammonium sulfate suspension |
| shipped in ambient | shipped in wet ice | shipped in ambient | shipped in - |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. 2-8°C |
| solubility 0.1 M imidazole buffer, pH 6.6: soluble, 0.5% NaHCO3, pH 9.0: soluble | solubility 0.25 M glycyl-glycine, pH 7.4: soluble 5.0 mg/mL, clear, colorless to slightly yellow | solubility aqueous buffer: soluble, water: soluble | solubility - |
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.



